Active Ingredient: VUTRISIRAN SODIUM
Proprietary Name: AMVUTTRA
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215515
Product Number: 001
Approval Date: Jun 13, 2022
Applicant Holder Full Name: ALNYLAM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
